By clicking below you acknowledge that you are navigating away from temaetfs.com and will be connected to temafunds. Tema Global Limited manages both domains. Please take note of Tema's privacy policy, terms of use, and disclosures that may vary between sites.
Start investing now
.svg){kind=small}
Start investing now
Invest directly by choosing one of the brokers below
Start investing now
Invest directly by choosing one of the brokers below
Start investing now
Invest directly by choosing one of the brokers below
Start investing now
Invest directly by choosing one of the brokers below
Start investing now
Invest directly by choosing one of the brokers below
Start investing now
Invest directly by choosing one of the brokers below
Your are leaving temaetfs.com
Which fund are you interested in?
Life Sciences
HRTS 
GLP-1, Obesity & Cardiometabolic ETF
CANC
Oncology ETF
MNTL
Neuroscience and Mental Health ETF
Strategic Equity
TOLL
Monopolies and Oligopolies ETF
RSHO
American Reshoring ETF
VOLT(coming soon)
Tema Electrification ETF
LUX
Luxury ETF
.svg){kind=small}
.svg){kind=icon}
Back
.png)
Yuri Khodjamirian, CFA
Recent Posts
What is ETF liquidity? ETF liquidity is an important consideration for investors because it impacts the ability to buy or sell an ETF at a reasonable...
Quarterly Market Commentary Equity markets returned another strong quarter in Q2 with the S&P 500 adding +4.3% and MSCI World +3.2%. One feature of...
HRTS name was updated to Tema GLP-1, Obesity & Cardiometabolic ETF. HRTS was the world’s first ETF investing in GLP-1 and weight loss drug trend. We...
According to IQVIA, if we include partnerships/collaborations, in 2023 there were 31 deals above the value of $2bn. Three major areas are emerging as...
M&A is picking up in the biopharma space. Seven names owned across our life science funds, especially in oncology, have received takeover offers. In...
Weight-loss drugs have seen tremendous growth since the approval in mid-2021 of Wegovy (the brand name of semaglutide, also found in Ozempic, and...
Quarterly Market Commentary Markets continued their rally in Q1 2024, clocking in +10.6% for the S&P 500 and 9.0% for MSCI World. Our guiding...
There are 24,000 listed equities in the world that meet the minimum inclusion criteria for our ETFs1. So how do we go from that to a final portfolio?...
Download as PDF
Quarterly Market Commentary The calendar often marks what are somewhat arbitrary posts along an investor’s journey and the year just gone as a case...
Tema’s active investment process consists of four key steps Each process step is either fundamental (human driven) and/or systematic (rules...
Artificial intelligence in the form of natural language models burst onto the scene with the launch of Chat GPT from Open AI, which gained one...
Once we establish that the company under analysis has solid foundations and meets pillar one (operating base) and pillar two (balance sheet and cash...
From technological leaps to socio-economic shifts, we unwind the key highlights of this year that will define the landscape of 2024 and the years...
When it comes to alpha generation, one thing matters most according to Institutional Investor1 – picking the right stocks.
Many active managers shy away from explicitly discussing edge in their investment process. Others give convoluted or complicated answers. We firmly...
If a person jumps out of a plane with a single parachute, their chances of it failing are 0.01%. If a person jumps out of a plane with two parachutes...
One of the surprising findings of a large academic study of 750 successful managers1 relates to portfolio construction. While this universe of...
In this edition of Tema Trends we: Ask ourselves whether the rapidly evolving technology sector has the potential to create enduring...
What does it mean to say a company has a good operating base? The concept, though not something that is used often in financial and business worlds,...
On May 11th , 2023 , Tema launched its first three funds.
Investing in the stock market can often be boiled down to understanding two seemingly simple, yet incredibly powerful, financial metrics – the...
Many equity investors now know that quality and competitive advantage (moats1) matters. However, identifying firms that can sustain these for the...
No results found